OmniAb OABI
NASDAQ OABI
$4.53 -0.22 (-4.74%)
As of: Sep 4, 2026 · 11:51 AM EDT

OmniAb (OABI) Consolidated Net Income (2021 - 2026)

OmniAb (OABI) posted quarterly Consolidated Net Income of -$7.7 million for Q1 2026, up 57.65% year-over-year from -$4.9 million in Q1 2025, and up 45.64% quarter-over-quarter from -$14.2 million in Q4 2025.

Analysis

OmniAb (OABI) Consolidated Net Income (2021 - 2026) Analysis & Trends

OmniAb (OABI) has reported Consolidated Net Income for 6 consecutive years, with -$7.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Consolidated Net Income rose 57.65% year-over-year to -$7.7 million; the TTM figure through Mar 2026 stood at -$54.3 million (up 11.4% YoY), while the FY2025 annual figure was -$64.8 million, down 4.43% from the prior year.
  • Consolidated Net Income improved to -$7.7 million in Q1 2026 per OABI's latest filing, from -$14.2 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $6.8 million in Q4 2022 and bottomed at -$19.0 million in Q1 2024.
  • Historically, Consolidated Net Income has averaged -$12.2 million across 5 years, with a median of -$14.1 million in 2023.
  • On a YoY basis, Consolidated Net Income climbed as much as 118.97% in 2022 and fell as far as 470197.48% in 2022.
  • OmniAb's Consolidated Net Income stood at $6.8 million in 2022, then sank by 306.06% to -$14.1 million in 2023, then gained by 7.01% to -$13.1 million in 2024, then slipped by 8.5% to -$14.2 million in 2025, then soared by 45.64% to -$7.7 million in 2026.
  • Business Quant data shows OABI's Consolidated Net Income at -$7.7 million in Q1 2026, -$14.2 million in Q4 2025, and -$16.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 140.21 Bn 132.36 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.73 Bn 58.55 Bn 1.37 Bn 601.00 Mn
4 Moderna 57.59 Bn 52.46 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -644.37 Mn
6 BeOne Medicines 40.13 Bn 35.04 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.55 Bn 32.24 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.60 Bn 27.77 Bn - 81.49 Mn
9 Insmed 27.70 Bn 26.54 Bn 358.27 Mn -13.27 Mn
10 OmniAb 582.80 Mn 530.80 Mn 12.81 Mn -5.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.86 Mn
Mar 31, 2026 -7.71 Mn
Dec 31, 2025 -14.18 Mn
Sep 30, 2025 -16.53 Mn
Jun 30, 2025 -15.88 Mn
Mar 31, 2025 -18.20 Mn
Dec 31, 2024 -13.07 Mn
Sep 30, 2024 -16.37 Mn
Jun 30, 2024 -13.63 Mn
Mar 31, 2024 -18.96 Mn
Dec 31, 2023 -14.05 Mn
Sep 30, 2023 -15.74 Mn
Jun 30, 2023 -14.73 Mn
Mar 31, 2023 -6.10 Mn
Dec 31, 2022 6.82 Mn
Sep 30, 2022 -12.60 Mn
Jun 30, 2022 -10.28 Mn
Mar 31, 2022 -6.28 Mn
Dec 31, 2021 -35.43 Mn
Sep 30, 2021 -170,579.00